Evidence map›Paper›PMID 28894978›Full record

ArticleInflammation2018

Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.

Feifei Xu, Shaoqing Yu, Mali Qin, Yong Mao, Ling Jin, Na Che, Shuangxi Liu, Rongming Ge

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. [Changes of nasal nitric oxide in the treatment of allergic rhinitis with hydrogen-rich saline lavage of nasal cavity].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2020
    Trial
  7. Review
  8. Article
  9. Research Progress of Molecular HDrug design, development and therapy · 2026
    Review
  10. Molecular Hydrogen in the Treatment of Respiratory Diseases.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Research Progress of Hydrogen on Chronic Nasal Inflammation.Journal of inflammation research · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Molecular hydrogen is a promising therapeutic agent for pulmonary disease.Journal of Zhejiang University. Science. B · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Feifei XuDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Shaoqing YuDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China. yu_shaoqing@163.com.ORCID http://orcid.org/0000-0003-2208-4535
Mali QinDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Yong MaoDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Ling JinDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Na CheDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Shuangxi LiuDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Rongming GeDepartment of Otorhinolaryngology, Head and Neck Surgery, Tongji Hospital, Tongji University, Shanghai, 200065, China.
Tongji University · CN

Funding

The Doctoral Program of the Ministry of Education 20130072120022Western Medicine guide project of Shanghai City 17411970500
6 · The paper itself

Abstract

It is well known that CD4+CD25+Foxp3+Treg cells play an important role in the development of allergic rhinitis (AR); the defect of cell numbers and functions contribute to AR. Hydrogen has been proven effective in alleviating symptoms of AR. We herein aim to verify the protective effects of hydrogen on CD4+CD25+Foxp3+Treg cells in guinea pigs with AR and to explore the effect of hydrogen-rich saline (HRS) on CD4+CD25+Foxp3+Treg cells in animals with AR and investigate the underlying anti-inflammatory mechanism. Eighteen guinea pigs were randomly divided into three groups (control group/AR group/AR-HRS group). The guinea pigs were injected with hydrogen-rich saline (AR-HRS group) for 10 days after sensitization. The control group was injected with an equal volume of normal saline. The number of sneezes, degree of runny nose, and nasal-rubbing movements were scored. Peripheral blood eosinophil count was recorded. The proportions of Th1/Th2 of the peripheral blood and the CD4+CD25+Foxp3+T cells in the CD4+T cells of the spleen and peripheral blood were determined by flow cytometry. The content of interleukin (IL)-10 and transforming growth factor (TGF)-β in the serum was detected by enzyme-linked immunosorbent assay (ELISA). The protein and mRNA expression of Foxp3, IL-10, and TGF-β were determined by Western blot, immunofluorescence, and real-time PCR analysis, respectively. Scores of symptoms, number of eosinophils,and nasal mucosa damage were dramatically reduced after HRS treatment. HRS increased the expression of Foxp3, IL-10, TGF-β, and number of CD4+CD25+Foxp3+Treg cells, which were reduced in AR. HRS also revised the dysregulation of Th1/Th2 balance. Both the number and biological activity of CD4+CD25+Foxp3+Treg cells increased with up-regulation of Th1/Th2 after HRS administration. HRS could play a protective role in attenuating AR through improving the proportion and functions of CD4+CD25+Foxp3+Treg cells.

Indexed as

AnimalsAnti-Inflammatory AgentsDisease Models, AnimalEosinophilsForkhead Transcription FactorsGuinea PigsInterleukin-10MaleNasal MucosaOvalbuminRhinitis, AllergicSignal TransductionSodium ChlorideSpleenTh1 CellsTh1-Th2 BalanceAnti-Inflammatory AgentsForkhead Transcription FactorsInterleukin-10OvalbuminSodium ChlorideTransforming Growth Factor betaallergic rhinitisguinea pighydrogen-rich salineregulatory T cellT-lymphocytes

Identifiers

PMID28894978
OpenAlexW2755176817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.